Seres Therapeutics Inc share price logo

Seres Therapeutics Inc Share Price

NASDAQ: MCRB

Small Cap

$18.87

+0.37

(+2.00%)

Live

as on

Seres Therapeutics Inc Stock Performance

as on September 5, 2025 at 12:35 am IST

  • Day's Low

    Day's High

    $17.82
    $18.92
    downward going graph

    5.56%

    Downside

    0.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.53
    $26.4
    downward going graph

    65.39%

    Downside

    39.90%

    Upside

    downward going graph

Seres Therapeutics Inc share price movements today

Previous Close
$18.50
Open
$18.13
Volume
239.3K
Day's Low - High
$17.82 - $18.92
52 Week Low - High
$6.53 - $26.4

Seres Therapeutics Inc Historical Returns

1 Month Return
+ 25.17 %
3 Month Return
+ 159.47 %
1 Year Return
+ 12.85 %
3 Year Return
-82.84 %
5 Year Return
-96.13 %

Seres Therapeutics Inc Stock Fundamentals & Key Indicators

Check Seres Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$170.9M

EPS (TTM)

1.75

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.74

Industry PE ratio

-163.63

P/B Ratio

0

PEG Ratio

-0.11

EBITDA

-105.5M

Revenue (TTM)

126.3M

Profit Margin

0.00%

Return On Equity TTM

6716900.00%

Seres Therapeutics Inc Stock Valuation

Track how Seres Therapeutics Inc P/E has moved over time to understand its valuation trends.

Seres Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 4, 2025

Industry (-163.63x)

September 4, 2025

Today (-0.74x)

September 4, 2025

Highest (0.00x)

September 4, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.74x

Seres Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Seres Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$170.9M-96.13%-0.740.00%
BUY$58.6B264.27%-505.15-12.96%
NA$39.4BNANA-3.89%
BUY$101.7BNA28.2531.86%
BUY$59.8B-2.85%14.2131.37%

Stock Returns calculator for Seres Therapeutics Inc Stock including INR - Dollar returns

The Seres Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Seres Therapeutics Inc investment value today

Current value as on today

₹1,20,146

Returns

₹20,146

(+20.15%)

Returns from Seres Therapeutics Inc Stock

₹15,131 (+15.13%)

Dollar Returns*

₹5,014 (+5.01%)

Analyst Recommendation on Seres Therapeutics Inc Stock

Based on 13 analysts

BUY

76.92%

Buy

15.38%

Hold

7.69%

Sell

Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Seres Therapeutics Inc. Average target price of $13.33

Seres Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Seres Therapeutics Inc.

What analysts predicted

-41.56%DOWNSIDE

Target Price

$13.33

Current Price

$18.87

Analyzed by

13 Analysts

Target

$13.33

Seres Therapeutics Inc target price $13.33, a slight downside of -41.56% compared to current price of $18.87. According to 13 analysts rating.

Seres Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Seres Therapeutics Inc Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Seres Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
126
0
0
-
-
-
5
-
-
Gross Profit
-4
124
-1
-3
-1
-1
-1
2
-3
-1
Operating Income
-70
49
-47
-39
-37
-28
-29
-28
-27
-24
EBITDA
-65
53
-39
-33
-33
-28
-49
-12
-27
-18
Interest Expense
1
3
4
4
4
3
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-71
46
-47
-34
-40
-32
-51
-15
32
-19
Income Tax Expense
0
0
1
-2
1
0
-
-
-
-
Net Income
-71
46
-47
-41
-40
-32
88
-15
32
-19
Net Profit Margin
13750.96%
36.81%
-15436.77%
-64450.00%
0.00%
0.00%
0.00%
-262.45%
0.00%
0.00%

Seres Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
21
32
28
34
33
144
7
126
-
Gross Profit
0
-60
-57
28
-45
-57
144
6
125
-14
Operating Income
-54
-92
-91
-100
-71
-88
-64
-246
-107
-121
EBITDA
-54
-88
-82
-92
-59
-77
-56
-237
-94
-111
Interest Expense
0
0
1
1
0
2
2
6
13
-
Depreciation
-
-
7
7
7
6
5
6
6
5
Income Before Tax
-54
-91
-89
-98
-70
-89
-65
-250
-113
-125
Income Tax Expense
0
2
-1
1
-6
-2
-4
3
14
0
Net Income
-54
-91
-89
-98
-70
-89
-65
-250
-113
0
Net Profit Margin
0.00%
-420.74%
-278.44%
-350.03%
-203.68%
-268.33%
-45.25%
-3509.50%
-90.02%
0.00%

Seres Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
46
-47
-41
-40
-32
88
-15
32
-19
Operating Cash Flow
65
-59
-47
-35
-39
-34
-38
26
-13
Investing Cash Flow
10
-1
0
0
1
141
0
0
0
Financing Cash Flow
58
1
6
18
-
-110
1
1
-
Change in Cash
134
-59
-41
-16
-38
-4
-37
28
-13

Seres Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-91
-89
-98
-70
-89
-65
-250
-113
0
Operating Cash Flow
43
-75
-62
-76
-93
6
-228
-117
-148
Investing Cash Flow
-65
56
112
-30
-158
64
82
10
142
Financing Cash Flow
2
0
0
86
303
1
129
71
-90
Change in Cash
-19
-18
49
-20
50
71
-16
-35
-96

Global Institutional Holdings in Seres Therapeutics Inc

Funds
Holdings
Vontobel Holding Ltd.
0.92%
SBI Securities Co Ltd
0.04%
Tudor Investment Corp Et AL
0.04%
CapTrust Financial Advisors
0.01%
U.S. Bancorp
0%

Insights on Seres Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 64.0K → 5.95M (in $), with an average increase of 98.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MCRB stock has moved up by 25.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 101.7% return, outperforming this stock by 184.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 78.4% return, outperforming this stock by 65.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 32.68M → -19.85M (in $), with an average decrease of 160.8% per quarter

About Seres Therapeutics Inc

seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.
OrganisationSeres Therapeutics Inc
Headquarters101 Cambridgepark Drive, Cambridge, MA, United States, 02140
IndustryHealth Technology
CEOMr. Thomas J. DesRosier Esq., J.D.
E-voting on sharesClick here to vote

Key Management of Seres Therapeutics Inc

Name

Title

Ms. Ann Kurowski

Senior Vice President of Regulatory Affairs

Ms. Kelly Brady

Senior Vice President of Clinical Development

Ms. Caroline Hensley

Assistant General Counsel

Mr. Thomas J. DesRosier Esq., J.D.

Co-CEO, Co-President & Chief Legal Officer

Dr. Matthew R. Henn Ph.D.

Executive VP & Chief Scientific Officer

Dr. Teresa L. Young Ph.D., R.Ph.

Executive VP and Chief Commercial & Strategy Officer

Mr. Chris McChalicher

Senior VP of Manufacturing, Quality, and Process Development

Dr. Dennis M. Walling M.D.

Senior VP of Clinical Development & Head of Clinical Research

FAQs

What is Seres Therapeutics Inc share price today?

Seres Therapeutics Inc share price today is $18.87 as on . Seres Therapeutics Inc share today touched a day high of $18.92 and a low of $17.82.

What is the 52 week high and 52 week low for Seres Therapeutics Inc share?

Seres Therapeutics Inc share touched a 52 week high of $26.4 on and a 52 week low of $6.53 on . Seres Therapeutics Inc stock price today i.e. is trending at $18.87,which is 28.52% down from its 52 week high and 188.97% up from its 52 week low.

What is Seres Therapeutics Inc's market capitalisation today?

Seres Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Seres Therapeutics Inc Stock (MCRB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Seres Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seres Therapeutics Inc Shares that will get you 0.0795 shares as per Seres Therapeutics Inc share price of $18.87 per share as on September 5, 2025 at 12:35 am IST.

What is the minimum amount required to buy Seres Therapeutics Inc Stock (MCRB) from India?

Indian investors can start investing in Seres Therapeutics Inc (MCRB) shares with as little as ₹88.115 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.15 in Seres Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Seres Therapeutics Inc share’s latest price of $18.87 as on September 5, 2025 at 12:35 am IST, you will get 0.5299 shares of Seres Therapeutics Inc. Learn more about fractional shares .

What are the returns that Seres Therapeutics Inc has given to Indian investors in the last 5 years?

Seres Therapeutics Inc stock has given -96.13% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?